BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28901318)

  • 1. Surgical treatment is an effective approach for patients with synchronous multiple primary lung cancers.
    Peng Y; Ren W; Wang H; Li M; Feng Z; Peng Z
    J Cancer Res Ther; 2017; 13(4):702-706. PubMed ID: 28901318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Surgical Treatment and Prognosis for Patients with 
Synchronous Multiple Primary Lung Adenocarcinomas].
    Peng Y; Wang H; Xie H; Ren W; Feng Z; Li M; Peng Z
    Zhongguo Fei Ai Za Zhi; 2017 Feb; 20(2):107-113. PubMed ID: 28228222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical results of synchronous multiple primary lung cancers: similar to the stage-matched solitary primary lung cancers?
    Yu YC; Hsu PK; Yeh YC; Huang CS; Hsieh CC; Chou TY; Hsu HS; Wu YC; Huang BS; Hsu WH
    Ann Thorac Surg; 2013 Dec; 96(6):1966-74. PubMed ID: 24021769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiological classification, gene-mutation status, and surgical prognosis of synchronous multiple primary lung cancer.
    Huo JW; Luo TY; He XQ; Gong JW; Lv FJ; Li Q
    Eur Radiol; 2022 Jun; 32(6):4264-4274. PubMed ID: 34989846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Survival after surgical treatment of bilateral synchronous multiple primary non-small cell lung cancers].
    Zhang ZR; Mao YS; Gao SG; Mu JW; Xue Q; Wang DL; Gao YS; Zhao J; He J
    Zhonghua Zhong Liu Za Zhi; 2016 Jun; 38(6):460-5. PubMed ID: 27346405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathology and genetic profile of synchronous multiple small adenocarcinomas: implication for surgical treatment of an uncommon lung malignancy.
    Lin MW; Wu CT; Kuo SW; Chang YL; Yang PC
    Ann Surg Oncol; 2014 Aug; 21(8):2555-62. PubMed ID: 24643899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical Prognosis of Synchronous Multiple Primary Lung Cancer: Systematic Review and Meta-Analysis.
    Nie Y; Wang X; Yang F; Zhou Z; Wang J; Chen K
    Clin Lung Cancer; 2021 Jul; 22(4):341-350.e3. PubMed ID: 33243621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonality status of multifocal lung adenocarcinomas based on the mutation patterns of EGFR and K-ras.
    Takamochi K; Oh S; Matsuoka J; Suzuki K
    Lung Cancer; 2012 Mar; 75(3):313-20. PubMed ID: 22209037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis on the Prognostic and Survival Factors of Synchronous Multiple Primary Lung Cancer].
    Guo H; Mao F; Zhang H; Qiu Y; Shen-Tu Y
    Zhongguo Fei Ai Za Zhi; 2017 Jan; 20(1):21-27. PubMed ID: 28103969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.
    Kadota K; Sima CS; Arcila ME; Hedvat C; Kris MG; Jones DR; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2016 Dec; 40(12):1579-1590. PubMed ID: 27740967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical outcomes of one-stage resection for synchronous multiple primary lung adenocarcinomas with no less than three lesions.
    Qu R; Tu D; Ping W; Cai Y; Zhang N; Fu X
    J Cardiothorac Surg; 2021 Sep; 16(1):265. PubMed ID: 34544453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and prognostic factors in surgically resected synchronous multiple primary lung cancers.
    Kocaturk CI; Gunluoglu MZ; Cansever L; Demir A; Cinar U; Dincer SI; Bedirhan MA
    Eur J Cardiothorac Surg; 2011 Feb; 39(2):160-6. PubMed ID: 20650645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic lung cancer subtype differentiates synchronous multiple primary lung adenocarcinomas from intrapulmonary metastases.
    Cheng H; Lei BF; Peng PJ; Lin YJ; Wang XJ
    J Surg Res; 2017 May; 211():215-222. PubMed ID: 28501120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical treatment of synchronous multiple primary lung cancers: a retrospective analysis of 122 patients.
    Liu M; He W; Yang J; Jiang G
    J Thorac Dis; 2016 Jun; 8(6):1197-204. PubMed ID: 27293837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of outcomes after surgical treatment of synchronous primary lung cancers.
    Finley DJ; Yoshizawa A; Travis W; Zhou Q; Seshan VE; Bains MS; Flores RM; Rizk N; Rusch VW; Park BJ
    J Thorac Oncol; 2010 Feb; 5(2):197-205. PubMed ID: 20101145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matched-pair analysis of a multi-institutional cohort reveals that epidermal growth factor receptor mutation is not a risk factor for postoperative recurrence of lung adenocarcinoma.
    Matsumura Y; Suzuki H; Ohira T; Shiono S; Abe J; Sagawa M; Sakurada A; Katahira M; Machida Y; Takahashi S; Okada Y
    Lung Cancer; 2017 Dec; 114():23-30. PubMed ID: 29173761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two lung adenocarcinomas in the same lobe: multiple primaries or intrapulmonary metastasis?
    Yoshimoto K; Yoshida J; Ishii G; Nishimura M; Hishida T; Nagai K
    Ann Thorac Cardiovasc Surg; 2011; 17(6):584-7. PubMed ID: 21881358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor mutation status is strongly associated with smoking status in patients undergoing surgical resection for lung adenocarcinoma.
    Matsumura Y; Owada Y; Inoue T; Watanabe Y; Yamaura T; Fukuhara M; Muto S; Okabe N; Hasegawa T; Hoshino M; Osugi J; Higuchi M; Suzuki H
    Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):690-695. PubMed ID: 29049789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of EGFR mutations in surgically resected pathological stage I lung adenocarcinoma.
    Nishii T; Yokose T; Miyagi Y; Daigo Y; Isaka T; Furumoto H; Ito H; Murakami S; Kondo T; Saito H; Oshita F; Yamada K; Matsukuma S; Nakayama H; Masuda M
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e204-e211. PubMed ID: 27349355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary Incidence of Synchronous Multiple Primary Lung Cancers and Survival in the Era of Lung Cancer Screening.
    Samadzadeh Tabrizi N; Gallant B; Harris E; Arnold BN; Fabian T
    Innovations (Phila); 2024; 19(1):23-29. PubMed ID: 38018766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.